Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma.

Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma. Cancer Res. 1999 Jul 01; 59(13):3064-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.